ACNO SOLUTION

Manufacturer
Noon Aesthetics M.R. Ltd
Effective date
2026-07-24
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
daily-update
Hydrated at
2026-07-29 05:10:14

Label at a glance#

ProductACNO Solution ACNE TREATMENT
Active ingredientSALICYLIC ACID
Label structure9 sections

Indications and uses

Use for the treatment of Acne.

Dosage and administration

Clean the skin thoroughly before applying this product. Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 0.5%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Uses

INDICATIONS & USAGE SECTION

  • Use for the treatment of Acne.

Warnings

WARNINGS SECTION

For external use only.

When using this product

OTC - WHEN USING SECTION

  • skin irritation and dryness are more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

  • If swallowed, get help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Clean the skin thoroughly before applying this product.
  • Cover the entire affected area with a thin layer one to three times daily.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water (Aqua), Methyl Perfluorobutyl Ether, Isododecane, Propanediol, Polymethylsilsesquioxane, Niacinamide, Glycerin, Polysilicone-11, Oryza Sativa Bran Extract, Boswellia Serrata Extract, Oligopeptide-10, Phenoxyethanol, Butylene Glycol, PPG-3 Benzyl Ether Myristate, Polysorbate 20, Triethanolamine, Hydroxyethylcellulose, Sodium Polyacrylate, Ethylhexyl Cocoate, Caprylyl Glycol, Decyl Glucoside, Cocamidopropyl Betaine, Hexylene Glycol, Sodium Sulfate, Sodium Benzoate, Honey Extract, Sodium Chloride.

SPL UNCLASSIFIED SECTION

Developed + Dist by
noon
AESTHETICS
TLV, 62153 | Made in Israel

PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

no
on
AESTHETICS

AcNo Solution
ACNE TREATMENT

NDC 78863-3002-1

15 mL / 0.5 Fl. Oz. ℮

PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton
PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 29 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
78863-300278863-3002-1, 78863-3002-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 28 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ACNO Solution ACNE TREATMENTSALICYLIC ACIDNoon Aesthetics M.R. Ltd4a267e44-03d9-471f-9708-a5c60ff690972026-07-24WarningsExact identifier
ndc (package): 78863-3002-2
ndc (package): 78863-3002-1
ndc (product): 78863-3002
ndc11 (package): 78863300201
ndc11 (package): 78863300202
spl id: 2553df56-d06c-4793-8dc5-3037807b17c2
spl set id: 4a267e44-03d9-471f-9708-a5c60ff69097

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.